Company Profiles

driven by the PitchBook Platform

Arcus Biosciences

Description

Developer of innovative cancer immunotherapies designed to treat cancer. The company's innovative cancer immunotherapies targets one or more therapeutic nodes and discover drugs that block tumors' ability to highjack the immune system, enabling patients to recover cancer.

2015

Founded

PRIVATE

Status

1-10

Employees

Series B

Latest Deal Type

$70M

Latest Deal Amount

$120M

Total Amount Raised

Description

Developer of innovative cancer immunotherapies designed to treat cancer. The company's innovative cancer immunotherapies targets one or more therapeutic nodes and discover drugs that block tumors' ability to highjack the immune system, enabling patients to recover cancer.

Website:

www.arcusbio.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery

Primary Office

3928 Point Eden Way Hayward, CA 94545United States +1 (510) 694-6200
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Arcus Biosciences's full profile, request a free trial.

    Arcus Biosciences Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Arcus Biosciences Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Arcus Biosciences Investors (10)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    CelgeneCorporationMinority000 0000000 0000
    Droia Oncology VenturesVenture CapitalMinority000 0000000 0000
    GVCorporate Venture CapitalMinority000 0000000 0000
    Invus GroupPE/BuyoutMinority000 0000000 0000
    Karl HandelsmanAngel (individual)Minority000 0000000 0000
    Celgene Corporation
    Droia Oncology Ventures Venture Capital
    GV Corporate Venture Capital
    Invus Group PE/Buyout
    Karl Handelsman Angel (individual)

    Arcus Biosciences Executive Team (8)

    NameTitleBoard
    Seat
    Contact
    Info
    Terry Rosen Ph.DCo-Founder and Chief Executive Officer
    Juan Jaen Ph.DCo-Founder & President
    Jennifer JarrettChief Business Officer and Chief Financial Officer
    Jay Powers Ph.DVice President, Drug Discovery
    Ulrike SchindlerVice President of Biology
    Terry Rosen Ph.D Co-Founder and Chief Executive Officer
    Juan Jaen Ph.D Co-Founder & President
    Jennifer Jarrett Chief Business Officer and Chief Financial Officer
    Jay Powers Ph.D Vice President, Drug Discovery
    Ulrike Schindler Vice President of Biology
    Request full access to PitchBook